1 results match your criteria: "Saskatoon City Hospital and the University of Saskatchewan[Affiliation]"
OCTA changes following loading phase with intravitreal aflibercept for DME.
Can J Ophthalmol
October 2023
Department of Ophthalmology, Saskatoon City Hospital and the University of Saskatchewan, Saskatoon, Sask; Saskatoon Retinal Consultants, Saskatoon, Sask.
Objective: To quantify changes in optical coherence tomography angiography (OCTA) parameters following intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema (DME), and to assess associations between pretreatment OCTA parameters and visual outcomes.
Design: Prospective cohort study.
Methods: Twenty-nine patients with DME received 5 monthly intravitreal injections of aflibercept.